Our mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology.
Mitochondria are essential energy-converting cellular organelles found in nearly every cell type throughout the body. Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondrial dysfunction also plays an important role in more common diseases, including aging-related disorders.
At Pretzel, we are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots. By taking aim at the genetic drivers of mitochondrial dysfunction, we believe our approach could be effective across a wide range of diseases which lack meaningful treatment options today.
Company Details
- Employees
- 47
- Address
- Boston, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pretzeltx.com
- Keywords
- Manager jobs.
- HQ
- Boston, MA
Pretzel Therapeutics Questions
Pretzel Therapeutics's website is https://www.pretzeltx.com
Pretzel Therapeutics's LinkedIn profile is https://www.linkedin.com/company/pretzeltx
Pretzel Therapeutics has
47 employees.
View email and phone details for 47
employees at Pretzel Therapeutics.
Pretzel Therapeutics's industry is
Biotechnology Research
Pretzel Therapeutics's top competitors are
Neumora,
Rome Therapeutics,
Amplitude Therapeutics,
Sionna Therapeutics,
Nimbus Therapeutics,
Interline Therapeutics,
Orbital Therapeutics,
Tessera Therapeutics,
Magnet Biomedicine,
Rapt Therapeutics.
Pretzel Therapeutics's categories are Biotechnology Research
